CISCRP Releases Trials Supplement in USA Today
As part of our newly launched National Clinical Trial Outreach and Awareness Initiative, which aims to inform the public and patients about the clinical research process, CISCRP is pleased to share a recent supplement on Clinical Trials that was published in USA Today. We teamed up with several leading organizations to develop the informational articles and laudatory materials. The USA Today supplement hit newsstands in a number of major cities and markets on May 12th.
Why is this important? Our goal is to provide general education about clinical research and honor clinical trial volunteers for their participation through a variety of mass media channels. This supplement is expected to reach more than 20 million people through print and digital release.
Click the image below to download the full Clinical Trials supplement.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
